214 related articles for article (PubMed ID: 24101493)
1. Intrinsic-mediated caspase activation is essential for cardiomyocyte hypertrophy.
Putinski C; Abdul-Ghani M; Stiles R; Brunette S; Dick SA; Fernando P; Megeney LA
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):E4079-87. PubMed ID: 24101493
[TBL] [Abstract][Full Text] [Related]
2. Evidence that apoptotic signalling in hypertrophic cardiomyocytes is determined by mitochondrial pathways involving protein kinase Cδ.
Xie MJ; Chang H; Wang YY; Zhang L; Song Z; Guo WG; Wang T; Che HL; Yu ZB
Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1120-8. PubMed ID: 20880184
[TBL] [Abstract][Full Text] [Related]
3. Taurine attenuates isoproterenol-induced H9c2 cardiomyocytes hypertrophy by improving antioxidative ability and inhibiting calpain-1-mediated apoptosis.
Li W; Yang J; Lyu Q; Wu G; Lin S; Yang Q; Hu J
Mol Cell Biochem; 2020 Jun; 469(1-2):119-132. PubMed ID: 32304004
[TBL] [Abstract][Full Text] [Related]
4. Analysis of p53 and NF-κB signaling in modulating the cardiomyocyte fate during hypertrophy.
Chatterjee A; Mir SA; Dutta D; Mitra A; Pathak K; Sarkar S
J Cell Physiol; 2011 Oct; 226(10):2543-54. PubMed ID: 21792911
[TBL] [Abstract][Full Text] [Related]
5. Caspase Cleavage of Gelsolin Is an Inductive Cue for Pathologic Cardiac Hypertrophy.
Putinski C; Abdul-Ghani M; Brunette S; Burgon PG; Megeney LA
J Am Heart Assoc; 2018 Dec; 7(23):e010404. PubMed ID: 30486716
[TBL] [Abstract][Full Text] [Related]
6. Exogenous hydrogen sulfide prevents cardiomyocyte apoptosis from cardiac hypertrophy induced by isoproterenol.
Lu F; Xing J; Zhang X; Dong S; Zhao Y; Wang L; Li H; Yang F; Xu C; Zhang W
Mol Cell Biochem; 2013 Sep; 381(1-2):41-50. PubMed ID: 23660955
[TBL] [Abstract][Full Text] [Related]
7. DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy.
Kuhn C; Frank D; Will R; Jaschinski C; Frauen R; Katus HA; Frey N
J Biol Chem; 2009 Jun; 284(25):17320-17327. PubMed ID: 19372220
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibition prevents and reverts cardiomyocyte hypertrophy.
Alvarez BV; Johnson DE; Sowah D; Soliman D; Light PE; Xia Y; Karmazyn M; Casey JR
J Physiol; 2007 Feb; 579(Pt 1):127-45. PubMed ID: 17124262
[TBL] [Abstract][Full Text] [Related]
9. In vivo administration of calpeptin attenuates calpain activation and cardiomyocyte loss in pressure-overloaded feline myocardium.
Mani SK; Shiraishi H; Balasubramanian S; Yamane K; Chellaiah M; Cooper G; Banik N; Zile MR; Kuppuswamy D
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H314-26. PubMed ID: 18487434
[TBL] [Abstract][Full Text] [Related]
10. Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy.
Hirotani S; Otsu K; Nishida K; Higuchi Y; Morita T; Nakayama H; Yamaguchi O; Mano T; Matsumura Y; Ueno H; Tada M; Hori M
Circulation; 2002 Jan; 105(4):509-15. PubMed ID: 11815436
[TBL] [Abstract][Full Text] [Related]
11. A20 is dynamically regulated in the heart and inhibits the hypertrophic response.
Cook SA; Novikov MS; Ahn Y; Matsui T; Rosenzweig A
Circulation; 2003 Aug; 108(6):664-7. PubMed ID: 12900338
[TBL] [Abstract][Full Text] [Related]
12. Adrenomedullin is a regulated modulator of neonatal cardiomyocyte hypertrophy in vitro.
Autelitano DJ; Ridings R; Tang F
Cardiovasc Res; 2001 Aug; 51(2):255-64. PubMed ID: 11470465
[TBL] [Abstract][Full Text] [Related]
13. Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.
Miller CL; Oikawa M; Cai Y; Wojtovich AP; Nagel DJ; Xu X; Xu H; Florio V; Rybalkin SD; Beavo JA; Chen YF; Li JD; Blaxall BC; Abe J; Yan C
Circ Res; 2009 Nov; 105(10):956-64. PubMed ID: 19797176
[TBL] [Abstract][Full Text] [Related]
14. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
[TBL] [Abstract][Full Text] [Related]
15. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor.
Thomas WG; Brandenburger Y; Autelitano DJ; Pham T; Qian H; Hannan RD
Circ Res; 2002 Feb; 90(2):135-42. PubMed ID: 11834705
[TBL] [Abstract][Full Text] [Related]
16. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.
Lu YM; Shioda N; Han F; Kamata A; Shirasaki Y; Qin ZH; Fukunaga K
Cardiovasc Ther; 2009; 27(1):17-27. PubMed ID: 19207476
[TBL] [Abstract][Full Text] [Related]
17. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1.
Rajapurohitam V; Javadov S; Purdham DM; Kirshenbaum LA; Karmazyn M
J Mol Cell Cardiol; 2006 Aug; 41(2):265-74. PubMed ID: 16806260
[TBL] [Abstract][Full Text] [Related]
18. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
[TBL] [Abstract][Full Text] [Related]
19. Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo.
Freund C; Schmidt-Ullrich R; Baurand A; Dunger S; Schneider W; Loser P; El-Jamali A; Dietz R; Scheidereit C; Bergmann MW
Circulation; 2005 May; 111(18):2319-25. PubMed ID: 15870116
[TBL] [Abstract][Full Text] [Related]
20. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
